학술논문
P.2.b.020 Safety and tolerability of levomilnacipran SR in major depressive disorder: results from an open-label, 48-week extension study
Document Type
Abstract
Author
Source
In European Neuropsychopharmacology October 2013 23 Supplement 2:S330-S330
Subject
Language
ISSN
0924-977X